Pressure BioSciences (OTCQB: PBIO), a leader in the
development and sale of broadly enabling, pressure-based instruments,
consumables, and platform technology solutions to the life sciences and other
industries, today announced that in 2019 – for the second straight year – over
20 scientific papers highlighting the advantages of PBI’s patented pressure
cycling technology (“PCT”) platform were published worldwide. The publications,
authored by independent scientists from academia, government, and industry,
highlighted the powerful and enabling benefits of the PCT Platform in such
critical areas as cancer research, food safety, and proteomics. “PCT-related
scientific papers published in 2019 highlighted new and/or improved
applications of the PCT Platform in a number of important and exciting areas of
research, including cancer, food safety, and proteomics,” PBI’s Global Director
of Sales and Marketing Roxana McCloskey said in the news release. “We are
particularly pleased that several publications described protocols for
combining the PCT Platform with existing technologies from other companies to
fill a significant unmet need for high throughput protein processing of cancer
biopsy tissues.”
To view the full press release, visit http://ibn.fm/Gpxin
About Pressure BioSciences Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the
development and sale of innovative, broadly enabling, pressure-based solutions
for the worldwide life sciences industry. The company’s products are based on
the unique properties of both constant (i.e., static) and alternating (i.e.,
pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented
enabling technology platform that uses alternating cycles of hydrostatic
pressure between ambient and ultra-high levels to safely and reproducibly
control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). PBIO’s
primary focus is in the development of PCT-based products for biomarker and
target discovery, drug design and development, biotherapeutics characterization
and quality control, soil & plant biology, forensics, and counter-bioterror
applications. Additionally, major new market opportunities have emerged in the
use of its pressure-based technologies in the following areas: (1) the use of
its recently acquired, patented technology from BaroFold, Inc. (the “BaroFold”
technology) to allow entry into the bio-pharma contract services sector, and
(2) the use of its recently-patented, scalable, high-efficiency, pressure-based
Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of
otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher
quality, homogenized, extended shelf-life or room temperature stable low-acid
liquid foods that cannot be effectively preserved using existing non-thermal
technologies. For more information, visit the company’s website at www.PressureBiosciences.com.
NOTE TO INVESTORS: The latest news and updates
relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks
are designed to keep investors up to date on important and breaking news in the
small-cap and micro-cap markets. Spanning all industries, including energy,
entertainment, telecommunications, healthcare, retail and more, these news breaks
deliver opportunities the investment community may have missed. Whether it is
earnings results, mergers and acquisitions, or any other market-moving news,
our news breaks keep you in the know. QualityStocks is committed to connecting
subscribers with companies that have huge potential to succeed in the short and
long-term future. It is part of our mission statement to help the investment
community discover emerging companies that offer excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment